Examining the Rise in Adult Acne in Women
Drug Topics
OCTOBER 6, 2022
Understanding the main causes and staying current on recommendations and treatments will help reduce patient rates of the condition.
Thu.Oct 06, 2022
469 
If patients aren’t benefiting from the 340B program, who is?
PhRMA
OCTOBER 6, 2022
The 340B Drug Pricing Program was designed to help vulnerable patients improve access to their medicines through manufacturer discounts to specific safety-net, non-profit hospitals and federally funded clinics. The biopharmaceutical industry has long supported this program, but unfortunately, 340B has strayed far from its purpose, with more and more for-profit health care entities using these discounts for themselves.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Co-Infection of HIV and Monkeypox Is Common
Drug Topics
OCTOBER 6, 2022
About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2000 monkeypox cases in the United States that occurred during the first 2 months of the outbreak.
Antioxidants: A New Therapy for Neurodegenerative Diseases?
Pharmacy Times
OCTOBER 6, 2022
Antioxidants are capable of converting highly destructive free radicals and nonradical molecules, thereby reducing cerebral stress.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
COVID-19 Vaccination Rates More Sluggish in Children Than Adults
Drug Topics
OCTOBER 6, 2022
Study links discrepancy to adults’ misbeliefs about vaccine safety.
Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 1 with Neil MacKinnon
Pharmacy Times
OCTOBER 6, 2022
Having a platform like Neil in a university to combat equity, diversity, and other measures in the public health space is a unique benefit as a pharmacist.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Call it data liberation day: Patients can now access all their health records digitally
STAT
OCTOBER 6, 2022
The American Revolution had July 4. The allies had D-Day. And now U.S. patients, held down for decades by information hoarders, can rally around a new turning point, October 6, 2022 — the day they got their health data back. Under federal rules taking effect Thursday, health care organizations must give patients unfettered access to their full health records in digital format.
Study Supports Link Between Inflammation, Cognitive Problems in Older Breast Cancer Survivors
Pharmacy Times
OCTOBER 6, 2022
Higher C-reactive protein levels have been linked to cognition problems among older breast cancer survivors.
Pfizer acquires Global Blood Therapeutics for $5.4bn
Pharmaceutical Technology
OCTOBER 6, 2022
Pfizer has acquired all the outstanding shares of the common stock of biopharmaceutical firm Global Blood Therapeutics (GBT) in a deal worth nearly $5.4bn. The total enterprise value comprised debt and the net of cash acquired. With the latest acquisition, GBT became a wholly-owned Pfizer subsidiary. GBT discovers and develops life-changing therapies for ailments with an initial focus on sickle cell disease (SCD).
Among Patients with Type 1 Diabetes, Woman May Be Less Likely Than Men to Receive Cardioprotective Medication for Cardiovascular Disease
Pharmacy Times
OCTOBER 6, 2022
Study finds cardioprotective medications were used in approximately 11% more men than women with type 1 diabetes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Products to Watch: HRG’s 5 new and noteworthy product picks from September 2022
Drug Store News
OCTOBER 6, 2022
From the 90 new products that hit store shelves in September, HRG’s new product team found five standouts.
Grant Awarded to Study Some of the Most Fatal Forms of Cancers
Pharmacy Times
OCTOBER 6, 2022
Two Houston Methodist cancer researchers were granted a quarter-million dollars each to study some of the most lethal forms cancer, including triple-negative breast cancer and multiple myeloma.
STAT+: Drugmakers will be penalized if they hike prices on patients in private insurance market
STAT
OCTOBER 6, 2022
WASHINGTON — Democrats’ drug pricing law will still penalize drugmakers if they hike prices on medicines for patients who have private insurance, a top Medicare official said Thursday. The penalties may factor into drugmakers’ decisions about how to price their medicines as the new law begins to take effect. Some experts and employers have been concerned that the drug pricing policy reforms that will save money in Medicare could incentivize drugmakers to try to charge
Whole Grain Consumption Associated With Reduced Risk of Premature Coronary Artery Disease
Pharmacy Times
OCTOBER 6, 2022
High intake of refined grains linked to an increased risk of premature coronary artery disease.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Early bird registration opens for DSN’s 2022 Industry Issues Summit
Drug Store News
OCTOBER 6, 2022
Now in its 24th year, the Industry Issues Summit is an opportunity to join retail executives at the premier conference for pharmacy, OTC, health, beauty and personal care.
Psychedelic Medicine Can Be an Important Tool to Boost Effective Treatment of Eating Disorders
Pharmacy Times
OCTOBER 6, 2022
New research suggests that psychedelics, and specifically ketamine, can increase neuroplasticity to help a patient with an eating disorder get “unstuck,” and help treat the disorder better than psychotherapy alone.
STAT+: ‘Patchy efforts’ by major insulin makers mean access lags in many poor countries
STAT
OCTOBER 6, 2022
The three companies that dominate the global market for insulin have launched various programs to expand the reach of their medicines in dozens of low and middle-income countries — but their efforts remain patchy and equitable access consequently remains out of reach, according to a new analysis. Too often, the manufacturers — Eli Lilly, Sanofi, and Novo Nordisk — do not understand the extent to which the public and private sectors in many poorer countries can afford insulin
Targeting G Protein–Coupled Receptors With CAR T-Cell Therapy Shows Promise Treating Multiple Myeloma
Pharmacy Times
OCTOBER 6, 2022
Researchers identified a new immunotherapeutic target that may be effectively treated with CAR T-cell therapy in patients with pretreated multiple myeloma.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Opinion: The new law that could stealthily transform biomedical innovation
STAT
OCTOBER 6, 2022
Buried deep within the Inflation Reduction Act’s drug-price negotiation provisions is language that could open the way to a new era of biomedical breakthroughs and smarter health spending. This language does something Medicare hasn’t tried before: It ties payment for treatments to how well they work. Doing so used to be illegal. But it will now be required for some drugs.
Gulf War Illness: How can disease modelling aid the search for a cure?
pharmaphorum
OCTOBER 6, 2022
Biological systems are hugely complex, with a staggering number of pathways interacting every millisecond. The downstream effects of just one biological change are enormous. So, when a new disease emerges, researchers have a near-impossible task working upstream from symptoms to identify the underlying cause and biological mechanisms causing disease.
Citing Ebola outbreak in Uganda, U.S. to screen all passengers arriving from there
STAT
OCTOBER 6, 2022
The United States is going to direct travelers arriving from Uganda, where a fast-growing Ebola outbreak arose in recent weeks, to five airports where they can be screened for possible infection. Starting Friday, U.S.-bound passengers who have been in Uganda within the past three weeks will be routed to JFK, Newark, Atlanta, O’Hare, or Dulles outside Washington, D.C., according to a statement from the U.S. embassy in Uganda.
Microbial identification market valued at $10.7 billion by 2032
European Pharmaceutical Review
OCTOBER 6, 2022
Microbial identification is a globally expanding market, predicted by new research to hold a value of $3.7 billion by the end of 2022 and $10.7 billion in 2032, propelled by a compound annual growth rate (CAGR) of 11.3 percent, led primarily by the rapid advancement of technology, In 2021, the market share for bacterial identification systems was 28.4 percent.
The U.S. is terrible at keeping businesses from worsening public health, experts say
STAT
OCTOBER 6, 2022
WASHINGTON – Here in the U.S., it’s “in” to study the social determinants of health. There are programs at Columbia and Emory dedicated to the field. Papers on the topic garner thousands of citations.The federal health department has even crafted an entire plan for addressing this topic, which is broadly defined as the ways a person’s environment impacts their health.
Health Innovators – Anthony Yanni Part One
pharmaphorum
OCTOBER 6, 2022
In this instalment of Health Innovators, Paul Tunnah, Healthware’s chief content officer, sits down with Dr Anthony Yanni, senior vice president and global head of patient centricity at Astellas Pharma. “Patient centricity” is a central value as pharma companies look to innovate their products and processes, but is it also in danger of losing its meaning and becoming just another pharma business buzzword?
Biden pardons thousands for possession of marijuana and moves toward reclassification
STAT
OCTOBER 6, 2022
WASHINGTON — President Joe Biden is pardoning thousands of Americans convicted of “simple possession” of marijuana under federal law, as his administration takes a dramatic step toward decriminalizing the drug and addressing charging practices that disproportionately impact people of color. Biden’s move also covers thousands convicted of the crime in the District of Columbia.
Cystic fibrosis phage therapy trial commences
European Pharmaceutical Review
OCTOBER 6, 2022
An early Phase Ib trial ( NCT05453578 ) funded by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Antibacterial Resistance Leadership Group (ARLG) has begun to evaluate if WRAIR-PAM-CF1, a bacteriophage therapy, is safe for use and lowers the presence of Pseudomonas aeruginos ( P. aeruginosa) bacteria in cystic fibrosis (CF) patients’ lungs.
STAT+: FDA and Covis release dueling documents over the fate of a controversial drug for premature births
STAT
OCTOBER 6, 2022
In the run-up to an extremely unusual hearing later this month, newly released documents underscore highly contrasting views taken by the U.S. Food and Drug Administration and a manufacturer toward a controversial drug for reducing premature births, which the agency wants withdrawn from the market. For the first time, the FDA has explained in copious detail why agency officials believe the medication, which is called Makena, should be removed.
Rebranded Servier eyes €3bn in cancer drug sales by 2030
pharmaphorum
OCTOBER 6, 2022
Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category. Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases.
Youth vaping rates appear to be dropping, but regulators and advocates aren’t satisfied
STAT
OCTOBER 6, 2022
WASHINGTON — A new survey from the CDC and the FDA suggests that youth vaping rates appear to be dropping, compared to pre-pandemic levels. Just over 9% of middle and high schoolers surveyed earlier this year reported currently using e-cigarettes, according to data published Thursday afternoon. Scientists caution against comparing the last few years too directly, given the disruptive effects of the coronavirus pandemic, but in 2019, 20% of middle and high school students reported current
Olay quenches skin thirst with Regenerist Hyaluronic + Peptide 24 collection
Drug Store News
OCTOBER 6, 2022
The Regenerist Hyaluronic + Peptide 24 collection is formulated to hydrate the skin’s surface and leave a dewy, radiant complexion, the brand said.
Listen: Nobels for science, biotech dealmaking, & a friendly FTC
STAT
OCTOBER 6, 2022
What can we learn from mummy DNA? Is Pfizer single-handedly propping up biotech? And how do you get molecules to “click”? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The newest Nobel laureates got their phone calls from Stockholm this week, and STAT science writer Megan Molteni joins us to explain their prize-winning work in medicine and chemistry.
CVS Health names Amar Desai to lead newly formed Health Care Delivery organization
Drug Store News
OCTOBER 6, 2022
Amar Desai will oversee the implementation of key areas of CVS Health's health services and care delivery strategy.
STAT+: Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help
STAT
OCTOBER 6, 2022
Telehealth company Ro has reached an agreement with the National Institute on Aging to create a registry of patients that could participate in Alzheimer’s disease research, a new approach to tackle the stubborn issue of recruitment for clinical trials. Ro, which is best known for prescribing hair loss and erectile dysfunction medication online, will use its platform to recruit and screen patients who may be at risk of Alzheimer’s or dementia.
Let's personalize your content